Self-Adhering Magnetic Device to Treat Corneal Exposure

Recruiting N/A Interventional Study
Paralytic Lagophthalmos Corneal Exposure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
25 (estimated)
Sponsor
University of Illinois at Chicago · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Males and females ages 18-80 years old. * Patients with recent corneal abrasion and no signs of infection in the examination * Patients with lagophthalmos * Normal Controls Exclusion Criteria: * Individuals with adhesive or tape allergies. * Individuals with a history of met…
Contacts

Van Ann Tran, MD

312-996-9120

annqtran@uic.edu

CONTACT